X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29537) 29537
Newspaper Article (2361) 2361
Newsletter (947) 947
Magazine Article (294) 294
Dissertation (172) 172
Book Chapter (153) 153
Conference Proceeding (94) 94
Book / eBook (59) 59
Transcript (48) 48
Publication (24) 24
Government Document (17) 17
Reference (13) 13
Paper (11) 11
Web Resource (11) 11
Report (10) 10
Journal / eJournal (9) 9
Trade Publication Article (6) 6
Book Review (4) 4
Streaming Video (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17374) 17374
bcg (10373) 10373
bcg vaccine (8358) 8358
animals (7536) 7536
female (7258) 7258
tuberculosis (6940) 6940
male (6930) 6930
vaccination (6446) 6446
bcg vaccines (4574) 4574
immunology (4451) 4451
mice (4278) 4278
mycobacterium bovis (4021) 4021
bcg vaccine - therapeutic use (3896) 3896
bcg vaccine - administration & dosage (3847) 3847
child (3686) 3686
adult (3365) 3365
tuberculosis - prevention & control (3112) 3112
infant (2958) 2958
middle aged (2835) 2835
bcg vaccine - immunology (2714) 2714
adolescent (2666) 2666
vaccines (2575) 2575
immunotherapy (2573) 2573
tuberculin test (2536) 2536
bcg vaccine - adverse effects (2465) 2465
infectious diseases (2405) 2405
child, preschool (2378) 2378
aged (2318) 2318
microbiology (2125) 2125
infection (2027) 2027
mycobacterium bovis - immunology (1878) 1878
research (1823) 1823
immunization (1790) 1790
mycobacterium tuberculosis - immunology (1781) 1781
tuberculosis - immunology (1766) 1766
infant, newborn (1582) 1582
bladder cancer (1522) 1522
urinary bladder neoplasms - therapy (1520) 1520
antigens (1504) 1504
mycobacterium tuberculosis (1496) 1496
administration, intravesical (1477) 1477
time factors (1402) 1402
cancer (1383) 1383
health aspects (1371) 1371
bcg vaccination (1361) 1361
tuberculosis, pulmonary - prevention & control (1324) 1324
urology & nephrology (1317) 1317
infections (1306) 1306
research article (1280) 1280
bovis bcg (1271) 1271
guinea pigs (1230) 1230
bacillus-calmette-guerin (1205) 1205
antigens, bacterial - immunology (1179) 1179
tuberculosis - epidemiology (1145) 1145
immunity (1113) 1113
analysis (1111) 1111
medicine, research & experimental (1105) 1105
children (1104) 1104
urinary bladder neoplasms - drug therapy (1084) 1084
risk factors (1065) 1065
mice, inbred c57bl (1058) 1058
respiratory system (1014) 1014
tuberculin (998) 998
urinary bladder neoplasms - pathology (995) 995
mycobacterium-tuberculosis (992) 992
vaccine (966) 966
macrophages (959) 959
medical research (956) 956
mycobacterium-bovis bcg (947) 947
diagnosis (939) 939
care and treatment (937) 937
mice, inbred balb c (920) 920
tuberculosis - diagnosis (910) 910
bcg vaccine - pharmacology (902) 902
forecasts and trends (891) 891
oncology (891) 891
proteins (878) 878
t-lymphocytes - immunology (859) 859
tuberculosis vaccines (851) 851
follow-up studies (850) 850
treatment outcome (841) 841
expression (831) 831
medicine, general & internal (815) 815
medicine (811) 811
immunity, cellular (795) 795
mycobacterium tuberculosis - genetics (786) 786
cattle (776) 776
immune response (770) 770
macrophages - immunology (768) 768
cytokines (749) 749
prevention (746) 746
interferon-gamma (744) 744
medicine, experimental (727) 727
aged, 80 and over (718) 718
disease models, animal (714) 714
therapy (710) 710
epidemiology (708) 708
growth (700) 700
skin tests (699) 699
multidisciplinary sciences (692) 692
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (47) 47
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Robarts - Government Pubs (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27232) 27232
French (1561) 1561
Russian (925) 925
German (911) 911
Japanese (794) 794
Spanish (607) 607
Chinese (472) 472
Italian (353) 353
Portuguese (328) 328
Polish (287) 287
Czech (122) 122
Hungarian (96) 96
Romanian (90) 90
Korean (76) 76
Swedish (70) 70
Croatian (60) 60
Dutch (52) 52
Turkish (32) 32
Norwegian (31) 31
Finnish (23) 23
Danish (21) 21
Hebrew (20) 20
Serbian (18) 18
Bulgarian (17) 17
Ukrainian (15) 15
Indonesian (10) 10
Slovak (10) 10
Persian (6) 6
Arabic (3) 3
Slovenian (3) 3
Afrikaans (2) 2
Azerbaijani (1) 1
Belarusian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 677 - 688
Abstract Background Whether the commonly used bacillus Calmette-Guérin (BCG) strains Connaught and Tice confer different treatment responses in... 
Urology | BCG Tice | Intravesical drug administration | Flow cytometry | Urinary bladder neoplasms | BCG Connaught | Immunotherapy | Animal | Models | BCG vaccine | Randomized controlled trial | MYCOBACTERIUM-TUBERCULOSIS | SURVIVAL | TOKYO | BOVIS BCG SUBSTRAINS | RISK | MODEL | ZINC | CARCINOMA IN-SITU | GENOME SEQUENCE | UROLOGY & NEPHROLOGY | SUPEROXIDE-DISMUTASE | Carcinoma, Transitional Cell - mortality | Immunotherapy - methods | Prospective Studies | Humans | Middle Aged | BCG Vaccine - classification | Male | Neoplasm Recurrence, Local - mortality | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Statistics, Nonparametric | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Female | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Risk Assessment | Mice, Inbred C57BL | Kaplan-Meier Estimate | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Animals | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Mice | Administration, Intravesical | BCG Vaccine - administration & dosage | BCG Vaccine/classification | Carcinoma, Transitional Cell/pathology | Immunotherapy/methods | Life Sciences | Carcinoma, Transitional Cell/drug therapy | Immunology | Carcinoma, Transitional Cell/mortality | Neoplasm Recurrence, Local/mortality | Urinary Bladder Neoplasms/drug therapy | Neoplasm Recurrence, Local/pathology | Urinary Bladder Neoplasms/pathology | BCG Vaccine/administration & dosage | Urinary Bladder Neoplasms/mortality
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 03/2019, Volume 25, Issue 3, pp. 451 - 456
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 08/2017, Volume 35, Issue 8, pp. 516 - 527
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 2, pp. 138 - 149
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2012, Volume 109, Issue 43, pp. 17537 - 17542
Journal Article
PLoS pathogens, ISSN 1553-7374, 2014, Volume 10, Issue 10, p. e1004485
The anti-tuberculosis-vaccine Bacillus Calmette-Guerin (BCG) is the most widely used vaccine in the world. In addition to its effects against tuberculosis, BCG... 
NATURAL-KILLER-CELLS | CHILD SURVIVAL | WEST-AFRICA | DENDRITIC CELLS | VACCINATION | MONOCYTES | RANDOMIZED-TRIAL | MICROBIOLOGY | CANDIDA-ALBICANS | VIROLOGY | IMMUNOTHERAPY | HOST-DEFENSE | PARASITOLOGY | Autophagy-Related Proteins | Adjuvants, Immunologic - administration & dosage | Mycobacterium bovis - immunology | Microtubule-Associated Proteins - genetics | Humans | Vaccination | Antineoplastic Agents - therapeutic use | Monocytes - immunology | Antineoplastic Agents - administration & dosage | Autophagy - immunology | Autophagy - genetics | Adjuvants, Immunologic - therapeutic use | Cytokines - metabolism | Vesicular Transport Proteins - genetics | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - virology | beta-Glucans - metabolism | Autophagy-Related Protein 5 | Urinary Bladder Neoplasms - immunology | Polymorphism, Single Nucleotide | Administration, Intravesical | BCG Vaccine - therapeutic use | BCG Vaccine - administration & dosage | Autophagy (Cytology) | Care and treatment | Immune response | Oncology, Experimental | Bacillus (Bacteria) | Research | Bladder cancer | Health aspects | Cancer | Immunological research | Mycobacterium bovis | Cytokines | Adjuvants, Immunologic | Microtubule-Associated Proteins | Antineoplastic Agents | Innate immunity | Urinary Bladder Neoplasms | Autophagy | Life Sciences | Monocytes | Immunology | BCG Vaccine | beta-Glucans | Vesicular Transport Proteins | Genotype & phenotype | Epigenetics | Software | Gene expression | Experiments | Immune system
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 59, Issue 6, pp. 997 - 1008
Abstract Context and objective To present the 2011 European Association of Urology (EAU) guidelines on non–muscle-invasive bladder cancer (NMIBC). Evidence... 
Urology | EAU Guidelines | Cystectomy | Transurethral resection (TUR) | Prognosis | Intravesical chemotherapy | Cystoscopy | Bacillus Calmette-Guérin (BCG) | Diagnosis | Urothelial carcinoma | Bladder cancer | Follow-up | BACILLUS-CALMETTE-GUERIN | EUROPEAN ORGANIZATION | PHOTODYNAMIC DIAGNOSIS | PROPHYLACTIC TREATMENT | INTRAVESICAL MITOMYCIN-C | TRANSITIONAL-CELL CARCINOMA | UROLOGY & NEPHROLOGY | TRANSURETHRAL RESECTION | LONG-TERM EFFICACY | IN-SITU | Bacillus Calmette-Guerin (BCG) | IMMEDIATE POSTOPERATIVE INSTILLATION | Urinary Bladder Neoplasms - diagnosis | Humans | Antineoplastic Agents - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Patient Selection | Time Factors | Antineoplastic Agents - adverse effects | Carcinoma - epidemiology | Urinary Bladder Neoplasms - pathology | Chemotherapy, Adjuvant | Urinary Bladder Neoplasms - epidemiology | Carcinoma - secondary | Drug Administration Schedule | Risk Assessment | Neoplasm Invasiveness | Risk Factors | Neoplasm Recurrence, Local | Carcinoma - diagnosis | Treatment Outcome | Evidence-Based Medicine | BCG Vaccine - adverse effects | Urinary Bladder Neoplasms - therapy | Carcinoma - therapy | Administration, Intravesical | Neoplasm Staging | BCG Vaccine - administration & dosage | Chemotherapy | Carcinoma | Oncology, Experimental | Research | Universities and colleges | Cancer
Journal Article